Brief Report: Accelerated Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice Lacking the Membrane-Bound Complement Regulator CD59
Author(s) -
Sheng Yun,
Viola Leung,
Marina Botto,
Joseph J. Boyle,
Dorian O. Haskard
Publication year - 2008
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.108.169912
Subject(s) - regulator , cd59 , microbiology and biotechnology , ldl receptor , lipoprotein , receptor , complement system , biology , low density lipoprotein , negative regulator , immunology , medicine , endocrinology , chemistry , cholesterol , antibody , biochemistry , signal transduction , gene
Whereas studies in humans and animal models have suggested a role for complement activation in atherosclerosis, there has been little analysis of the importance of complement regulators. We tested the hypothesis that the terminal pathway inhibitor CD59 plays an essential role in limiting the proinflammatory effects of complement activation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom